Serum NfL Association With Progression in Relapsing–Remitting MS Treated With Natalizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis
Neurology 2021 Nov 09;97(19)e1898-e1905, C Bridel, CE Leurs, ZYGJ van Lierop, ZLE van Kempen, I Dekker, HAM Twaalfhoven, B Moraal, F Barkhof, BMJ Uitdehaag, J Killestein, CE TeunissenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.